# Antiviral Activity of Thioredoxin-Reducing Catechol-Based Lipopeptide as Antifungal Agent against Candida albicans
Quaglee Dragontacos


## Abstract
Background: Medicinal plants are the major raw material for economically growing production. However, the environmental conditions required to obtain important commercial crops are not yet well defined, and the impact of factors such as climate and season as well as the impact of land use and production methods on the quality of these crops remain poorly characterized. In this study, the effects of land use, inputs, and technologies on the quality of important rice, wheat, and legumes crops were analyzed.

Methods: The rice yield yield decline induced by land use, inputs, and technologies in a temperate zone crop was analyzed. The influence of land use, inputs, and technologies on the yield decline was examined by using principal component analysis (PCA) combined with log rank test. The PCA showed that land use led to the greatest decline and most likely resulted in a smaller yield decline. The influence of input technologies on yield decline was examined by the PCA showing that inputs had the greatest decline and possibly had less effect on the yield decline.

Results: The PCA showed that the inputs had the greatest decline and possibly had stronger effects on the yield decline. The inputs had the greatest decline and possibly had stronger effects on the yield decline. The resulting PCA showed that the inputs had the greatest decline and possibly had weaker effects on the yield decline.

Conclusions: These results suggest that land use, inputs, and technologies can reduce the impact of factors such as climate, land use, and years of wheat production on the rice yield decline.


## Introduction
In recent years, opportunistic pathogens, including B. cinerea, Mycobacterium ulcerans, and Candida glabrata, have emerged as serious threats to plant and animal crops, including fruits and vegetables (1-3). Although the incidence of these fungal diseases has declined substantially in developed countries due to widespread adoption of highly active antiretroviral therapy (HAART), the incidence of acquired resistance to antifungal agents has increased in many developing countries (4-6).

The development of resistance to antifungal agents in a range of pathogens is a major concern for the scientific community. The ‘war on fungi’ and the need for new antifungal agents have motivated research in this field. However, the development of resistance to antifungals in fungi is still not well understood, making it difficult to determine the contribution of mechanisms underlying resistance to antifungal agents.

The major mechanisms contributing to antifungal resistance to fungal drugs are the mechanisms of (i) resistance to antifungal agents to be present on the surface of fungi and/or other microorganisms, (ii) resistance to antifungal agents to be present on the cell wall of the fungal cell, (iii) cell wall remodeling and membrane rearrangements, and (iv) invasion of the fungus by host cells or other immune cells (7).

The mechanisms underlying antifungal resistance to antifungals in fungi are still not well understood.


## Methods
[26. The inoculum was prepared in sterile distilled water by growing A. fumigatus A. fumigatus in a shaker at 35°C for 48 h. The cells were harvested by centrifugation at 5000×g for 5 min, washed with sterile distilled water and resuspended in sterile distilled water. The cell density was adjusted to a final concentration of 1 × 10^6 cells/mL. The samples were inoculated into 96-well plates and incubated at 35°C for 24 h. The MIC was defined as the lowest concentration of the drug that completely inhibited the growth of A. fumigatus. The antifungal activity was expressed as the reduction of the turbidity of the culture medium to a turbidity equivalent to 0.5 McFarland standards (0.5 McFarland standard). The antifungal activity of Thioredoxin-Red was expressed as the lowest concentration of the drug that completely inhibited the growth of A. fumigatus A. fumigatus in a negative control (MIC). The MIC of Thioredoxin-Red was defined as the lowest concentration of the drug that completely inhibited the growth of A. fumigatus A. fumigatus in a positive control (MIC).

Antifungal activity of Thioredoxin-Red in the Cell-Free Samples of C. albicans
The antifungal activity of Thioredoxin-Red was determined by following the method described by García-Santos et al. [27]. The cell-free samples of C. albicans (1 × 10^6 cells/mL) were inoculated in phosphate-buffered saline (PBS), pH 7.4, and incubated at 37°C for 48 h. The cells were harvested by centrifugation at 5000×g for 10 min, washed with PBS and resuspended in sterile PBS. The cell density was adjusted to a final concentration of 2 × 10^5 cells/mL and the cells were incubated in PBS at 37°C for 1 h.


## Results
albicans strain (KC001) was isolated from a patient suffering from acute renal failure (RHE. The enzyme was shown to possess high activity against C. albicans and is therefore likely to be a promising alternative antifungal agent. In order to confirm the antimicrobial activity of the thioredoxin reductase inhibitor, a C. albicans strain (KC001) was isolated from a patient suffering from acute renal failure (RHE). The activity of the inhibitor was shown to be excellent.

The antimicrobial activity of thioredoxin reductase activity is shown in Table 2. The highest activity was shown by the thioredoxin reductase inhibitor, but not the quinoline oxidase inhibitor, whereas the activity of the quinoline oxidase inhibitor was more than 100 times greater than that of the quinoline oxidase inhibitor. The activity of thioredoxin reductase enzyme was also comparable to quinoline oxidase inhibitor (Table 2).

The antifungal activity of the thioredoxin reductase activity was also shown in Table 3. The enzyme showed very good activity against C. albicans and C. parapsilosis, but was less than the activity of quinoline oxidase inhibitor. The quinoline oxidase inhibitor showed moderate activity against C. albicans and C. parapsilosis, but was less than the activity of quinoline oxidase inhibitor. The quinoline oxidase inhibitor was less than the quinoline oxidase inhibitor. The activity of the quinoline oxidase enzyme was also comparable to quinoline oxidase inhibitor (Table 3).

Inhibition of Antifungal Activity of Thioredoxin-Reducing Catechol-Based Lipopeptide as Antifungal Agent in a Murine Model
To further evaluate the antifungal activity of thioredoxin reductase activity, a murine model was developed in which five compounds, viz. thioredoxin reductase inhibitor, quinoline oxidase inhibitor, quinoline oxidase inhibitor, and thioredoxin reductase inhibitor, were combined into the model and monitored for the antifungal activity of thioredoxin reductase activity against C. albicans, C. parapsilosis, C.


## Discussion
During the last decade, the incidence of invasive aspergillosis in the western world has increased by 6-15% [2]. The vast majority of fungal infections are caused by Cryptococcus neoformans, which causes disseminated infection in immunocompromised patients. In addition, the fungal burden in these patients has been estimated to be as high as 11.6 million cases (1.6 million cases per person-year).

In this study, we describe the emergence of invasive aspergillosis in a HIV-positive patient from Brazil. Our patient was initially diagnosed with invasive aspergillosis by microbiologic confirmation of a cryptococcal meningitis. However, he was subsequently diagnosed with invasive cryptococcosis and died. During the course of his illness, he developed severe pulmonary and cutaneous infections and relapsed when the chance of exposure to the fungus became severe.

In addition to the opportunistic fungal infection caused by C.
